EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Revisiting the relevance of Hirano bodies in neurodegenerative diseases

Koji Yoshida, Shelley L Forrest, Shojiro Ichimata, Hidetomo Tanaka, Tomoya Kon, Maria Carmela Tartaglia, Charles H Tator, Anthony E Lang, Naoki Nishida iD, Gabor G Kovacs iD

Neuropathology and Applied Neurobiology · 2024

DOI: 10.1111/nan.12978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2024. Verfasst von Koji Yoshida und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology and Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Lewy Body Disease, Supranuclear Palsy, Progressive, Multiple System Atrophy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Edmond J. Safra Philanthropic Foundation, National Institute on Aging of the National Institutes of Health, Rossy Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Hirano bodies (HBs) are eosinophilic pathological structures with two morphological phenotypes commonly found in the hippocampal CA1 region in Alzheimer's disease (AD). This study evaluated the prevalence and distribution of HBs in AD and other neurodegenerative diseases.

Methods

This cross‐sectional study systematically evaluated HBs in a cohort of 193 cases with major neurodegenerative diseases, including AD ( n = 91), Lewy body disease (LBD, n = 87), progressive supranuclear palsy (PSP, n = 36), multiple system atrophy (MSA, n = 14) and controls ( n = 26). The prevalence, number and morphology of HBs in the stratum lacunosum (HBL) and CA1 pyramidal cell layer were examined. In addition, we investigated the presence of HBs in five additional hippocampal subregions.

Results

The morphological types of HBs in CA1 were divided into three, including a newly discovered type, and were evaluated separately, with their morphology confirmed in three dimensions: (1) classic rod‐shaped HB (CHB), (2) balloon‐shaped HB (BHB) and the newly described (3) string‐shaped HB (SHB). The prevalence of each HB type differed between disease groups: Compared with controls, for CHB in AD, AD + LBD, PSP and corticobasal degeneration, for BHB in AD + LBD and PSP, and SHB in AD + LBD and PSP were significantly increased. Regression analysis showed that CHBs were independently associated with higher Braak NFT stage, BHBs with LBD and TDP‐43 pathology, SHBs with higher Braak NFT stage, PSP and argyrophilic grain disease and HBLs with MSA.

Conclusions

This study demonstrates that HBs are associated with diverse neurodegenerative diseases and shows that morphological types appear distinctively in various conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseLewy Body DiseaseSupranuclear Palsy, ProgressiveMultiple System AtrophyHumansCross-Sectional Studies

Stichwörter der Autor:innen

Alzheimer's diseaseHirano bodyLewy body diseaseTDP‐43 proteinopathyargyrophilic grain diseasehippocampusmultiple system atrophyprogressive supranuclear palsy

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathobiology and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Tanz Centre for Research in Neurodegenerative Disease, Krembil Discovery Tower, University of Toronto, Toronto, Ontario, Canada.
  • Department of Legal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan.
  • Laboratory Medicine Program & Krembil Brain Institute, University Health Network, Toronto, Ontario, Canada.
  • Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
  • Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.

ORCID-Profile: Naoki Nishida, Gabor G Kovacs

Förderung

  • Edmond J. Safra Philanthropic Foundation
  • National Institute on Aging of the National Institutes of Health
  • Rossy Family Foundation
  • Canada Foundation for Innovation

Zitieren

APA

Yoshida, K., Forrest, S. L., Ichimata, S., Tanaka, H., Kon, T., Tartaglia, M. C., Tator, C. H., Lang, A. E., Nishida, N., & Kovacs, G. G. (2024). Revisiting the relevance of Hirano bodies in neurodegenerative diseases. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12978

Vancouver

Yoshida K, Forrest SL, Ichimata S, Tanaka H, Kon T, Tartaglia MC, et al. Revisiting the relevance of Hirano bodies in neurodegenerative diseases. Neuropathology and Applied Neurobiology. 2024. doi:10.1111/nan.12978

BibTeX
@article{Yoshida2024,
  author = {Yoshida, Koji and Forrest, Shelley L and Ichimata, Shojiro and Tanaka, Hidetomo and Kon, Tomoya and Tartaglia, Maria Carmela and Tator, Charles H and Lang, Anthony E and Nishida, Naoki and Kovacs, Gabor G},
  title = {Revisiting the relevance of Hirano bodies in neurodegenerative diseases},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2024},
  doi = {10.1111/nan.12978}
}
Kostenlos starten →